Navigation

Search This Site

Office of the Vice President for Research

Opportunities Related to COVID-19

Resources for Researchers Related to COVID-19

Funding Opportunities Related to COVID-19

The following table lists funding opportunities relating to the COVID-19 virus. We will continue to update this list as new opportunities become available. If you would like to add opportunities to this list please feel free to contact Dean Evasius.

Sponsor

Program Name and Link

First Due Date(s)

Notes

AHA AHA Rapid Response Grant COVID-19 and Its Cardiovascular Impact 4/6/2020 Grant amounts will be up to $100,000. AHA anticipates funding at least 10 awards.
Amazon AWS Diagnostic Development Initiative (DDI) 6/30/2020 Provides support for innovation in rapid and accurate patient testing for 2019 novel coronavirus (COVID-19), and other diagnostic solutions to mitigate future outbreaks.
AHRQ Notice of Intent: Revision Supplements to Existing AHRQ Grants and Cooperative Agreements to Address Health System Responsiveness to COVID-19   AHRQ intends to publish a new funding notice allowing requests for urgent revision supplements to existing AHRQ grants and cooperative agreements to address health system responsiveness to COVID-19.
AHRQ Notice of Intent: New Funding Opportunity Announcement to Support Novel, High-Impact Studies Evaluating Health System and Healthcare Professional Responsiveness to COVID-19   AHRQ is working to publish the FOA in early May 2020 with submissions due in June 2020.The health systems research community should prepare to submit applications to AHRQ to fund critical research focused on evaluating topics such as innovations and challenges encountered in the rapid expansion of telemedicine in response to COVID-19, effects on quality,
BARDA Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA) 4/30/2020  
Campus Consortium C19 Artificial Intelligence for Rapid Response Grant 4/3/2020 Designed to help schools address the high call and query volume they are receiving by providing Unifyed’s Yoda Rapid Response, an AI-enabled chat service that can help answer FAQ and provide self-help assistance to students, faculty and staff. The Artificial Intelligence for Rapid Response Grant will provide awarded institutions with the requisite licenses and services to a comprehensive Artificial Intelligence solution.
CDC Strengthening Global Field Epidemiology Training Program (FETP) Network 4/27/2020
Development of a well-trained epidemiologic public health workforce in surveillance, outbreak detection and response is essential in meeting Global Health Security objectives.
CDC Enhancing Global Health Security: Expanding Efforts and Strategies to Protect and Improve Public Health Globally 4/27/2020 The CDC seeks to accelerate progress toward a world safe and secure from infectious disease threats and to promote global health security as an international security priority.
CDC Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nations Health 4/2/2020 This is a forecast for an emergency supplemental funding opportunity announcement in response to the current outbreak of Coronavirus disease 2019 (COVID-19).
CDC CDC Coronavirus Response Fellowship 5/1/2020  The qualified candidate should be pursuing or have completed a degree in one of the relevant fields.
CDC Centers for Disease Control COVID-19 Broad Agency Announcement 3/25/2020  
DTRA Strategic Trends Division Broad Agency Announcement (BAA) 3/4/2020 Posted March 4, 2020
DOD Prototype Development to Combat Novel Coronavirus Disease COVID-19 4/15/2020 The Medical Technology Enterprise Consortium (MTEC) is excited to post this pre-announcement for a potential Request for Project Proposals (RPP) focused on the development of prototypes aimed to combat the coronavirus (COVID-19).
GIDI COVID-19 Rapid Response Grants 3/27/2020 Rapid Response Grants from the UVA Global Infectious Diseases Institute (GIDI)
Mozilla The Mozilla Open Source Support (MOSS) awards program   Tracks I and II and this new COVID-19 Solutions Fund accept applications on a rolling basis.
MTEC Pre-Announcement for MTEC-20-10-COVID19-NETCCN - "National Emergency Telecritical Care Network (NETCCN) Project"    This upcoming RPP will focus on enhanced development of integrated technologies and clinical workflows to establish and rapidly scale virtual wards.
MTEC Development of Treatments for COVID-19 4/8/2020

FOCUS AREA: Therapeutic(s) that can treat COVID-19.  Treatments with potential application to the prevention of COVID-19 infection are desired.  Therapeutics that can be administered in a non-hospital environment are desired. Potential applicants should work with their school’s respective grants offices to submit the white paper.

MTEC Prototype Development to Combat Novel Coronavirus Disease COVID-19 4/15/2020 This pre-announcement has been developed by MTEC to provide notice for the possibility of one or more upcoming RPPs focused on combating COVID-19.
NIAID Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)   Applications will be accepted on a rolling basis 03/25/2020 from 03/25/2021
NIAID Notice of Special Interest (NOSI): Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)   This notice applies to due dates on or after April 5, 2020 and subsequent receipt dates through April 5, 2021.
NIAID 2020 NIAID Omnibus Broad Agency Announcement 4/9/2020  
NIH Notice of Early Expiration of "Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (2019-nCoV)," NOT-AI-20-030   The purpose of this Notice is to inform the extramural community that NOT-AI-20-030, “Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (2019-nCoV)” will be rescinded as of 04/08/2020 . NOT-AI-20-030 will be replaced by NOT-AI-20-034 for NIAID competitive revisions and NOT-GM-20-025 for NIGMS competitive revisions,
NIH Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus 2/6/2020 rolling basis. Please see early expiration notice above.
NIH Partnerships for Countermeasures against Select Pathogens (R01 Clinical Trials Not Allowed) 6/29/2020  
NIH Collaborative Cross (CC) Mouse Model Generation and Discovery of Immunoregulatory Mechanisms (R21 Clinical Trial Not Allowed) 9/9/2020  
NIH Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus 3/19/2020 supplement to existing awards. 
NIH Notice of Special Interest (NOSI): Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) 3/17/2020  
NIH Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)   continuous submission
NIH Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required) 5/13/2020  
NIH Partnerships for Countermeasures against Select Pathogens (R01 Clinical Trials Not Allowed) 6/29/2020
Antiviral categories supported by this FOA include, but are not limited to, broad-spectrum antivirals, immunotherapeutics ... COVID-19
NIH Collaborative Cross (CC) Mouse Model Generation and Discovery of Immunoregulatory Mechanisms (R21 Clinical Trial Not Allowed) 9/9/2020 mouse models has addressed the impact of host genetic variation on immunity to emerging viral pathogens, including Norovirus, severe acute respiratory coronavirus (SARS-CoV), Ebola, West Nile Virus, Dengue virus, Zika virus, Hepatitis C virus),
NIH Travel and Subsistence Funding to Support LMIC Engagement During the COVID-19 Outbreak - Applicant Guidance 5/30/2020 continuous submission
NSF Dear Colleague Letter: Request for SBIR/STTR Phase I Proposals Addressing COVID-19   All active NSF SBIR/STTR awardees, and other interested US-based small businesses are eligible to submit a Phase I proposal. Please reference the NSF SBIR and STTR Phase I solicitations for more details regarding eligibility.
NSF Provisioning Advanced Cyberinfrastructure to Further Research on the Coronavirus Disease 2019 (COVID-19)   Before submitting a RAPID proposal or supplemental funding request in response to this DCL, investigators must first contact one of the cognizant OAC program officers listed
NSF Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19)   check with PO
Russell Sage Foundation New Funding Guidelines for May 21 Deadline 5/21/2020

For the upcoming deadline RSF will only consider LOIs that satisfy at least one of the following criteria:

(a) The research is so timely and time-sensitive that the project must start before April 1, 2021;or

(b) the research analyzes social, political, economic, or psychological disruptions resulting from the coronavirus crisis that affect social and living conditions in the United States.

Smart Cville

Microgrants for Community Based Responses to COVID-19

  Each microgrant is worth up to $200 and grant applications will be open until the money is exhausted.
XSEDE COVID-19 HPC Consortium   Continuous submission. To request access to resources of the COVID-19 HPC Consortium, you must prepare a description, no longer than two pages, of your proposed work.